Empagliflozin: A Comprehensive Guide to the Game-Changer in Diabetes and Heart Health
Empagliflozin: A Comprehensive Guide to the Game-Changer in Diabetes and Heart Health Introduction Diabetes mellitus, particularly type 2 diabetes (T2D), is a chronic metabolic disease that affects hundreds of millions globally. Alongside its hallmark symptom of elevated blood glucose levels, T2D is notorious for significantly increasing the risk of cardiovascular disease, kidney failure, and premature death. In the past decade, a new class of antidiabetic drugs—SGLT2 inhibitors—has transformed how we manage these risks. Among them, [...]